A new Lyme disease vaccine developed by Pfizer and Valneva is being tested in late-stage clinical trials. There hasn't been a Lyme disease vaccine available in the United States since 2002, when Lymetrix was pulled off the market due to low demand. Case rates have skyrocketed since the early 1990s. Pennsylvania sees more cases than any other state.
Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years in hopes of better fighting the tick-borne threat.
Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years in hopes of better fighting the tick-borne threat.